PCSK9-inhibitors Take Center Stage at ACC

Six Phase III clinical trials involving PCSK9-inhibitors will be presented at the ACC Scientific Sessions in Washington, DC. Two have been accepted for the Late-Breaking Clinical Trials Sessions, GAUSS-2 and LAPLACE-2. 

SELF STUDY

Exploring the Future of Acute Heart Failure Management: A Review of the Evidence
 
A Case Based Approach to Improving the Management of Acute Coronary Syndrome in the Emergency Room
 
Refining Type 2 Diabetes Management: Hitting the Right Glycemic Targets with Long Acting GLP-1 Receptor Agonists

CONFERENCES

VBWG Global Chapter Meeting
November 15, 2014
Chicago, IL

45th Annual Topics in Internal Medicine
September18-20, 2014
Orlando, FL

http://topics.cme.ufl.edu

Women and Heart Disease: Where Are We Now?
October 18, 2014
Jacksonville, FL

http://womensheart.cme.ufl.edu

Vascular Biology in Clinical Practice TM Vol. 7, No. 2

New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy

This monograph, New Frontiers in CVD Risk Management Supporting Early Aggressive Therapy , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 7, No. 1

ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection

This monograph, ACE Inhibition in CAD Patients: Expanding the Reach of Cardioprotection , which is being offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.

Vascular Biology in Clinical Practice © Vol. 6, No. 3

A HOPE FOR PEACE? Update on the role of ACE inhibition in CAD patients

This monograph, A HOPE for PEACE? Update on the role of ACE inhibition in CAD patients , is offered as part of a series of continuing medical education activities from the University of Florida College of Medicine.